Since the discovery of JAK2V617F, CALR, and MPL mutations as phenotypic driver mutations in essential thrombocytosis (9–11), the diagnostic workup of patients with essential thrombocytosis has been characterized by molecular study (12). Here, MPL is linked to essential thrombocythemia.